Evaluation of Parkinson disease risk variants as expression-QTLs.
about
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson diseaseGenomic copy number variants: evidence for association with antibody response to anthrax vaccine adsorbedSynthesis of 53 tissue and cell line expression QTL datasets reveals master eQTLs.Targeting GTPases in Parkinson's disease: comparison to the historic path of kinase drug discovery and perspectivesArizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes.Common Genetic Variant Association with Altered HLA Expression, Synergy with Pyrethroid Exposure, and Risk for Parkinson's Disease: An Observational and Case-Control Study.Comprehensive promoter level expression quantitative trait loci analysis of the human frontal lobe.Rit subfamily small GTPases: regulators in neuronal differentiation and survival.Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson's disease on chromosome 7p15.3.A Novel Relationship for Schizophrenia, Bipolar, and Major Depressive Disorder. Part 8: a Hint from Chromosome 8 High Density Association Screen.RIT2 Polymorphisms: Is There a Differential Association?Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.
P2860
Q24336432-7A739FD7-C806-447D-971A-64D88A60C144Q28383704-1E4CC287-51A9-4CB8-B04A-2FB20AA9E75AQ33917269-C7BEF30A-B095-4E55-8865-63A9D5561FF1Q35187475-BB2E3A63-B9A5-487F-A244-69BEA08624ABQ36121377-4EF4484B-6571-45BC-8F3D-67C553D5B7C6Q36346103-9899E6FA-6CE8-4CE2-908F-EBC65505FD84Q36858244-7C34B4AA-052B-4D7E-9A28-13286F191D52Q36994687-BDFFB655-5181-4103-B32C-417D2D910AA8Q37173904-2740DACF-70EC-4977-BF36-AE0A4B9548CCQ41095173-8391B085-E248-4D25-8AA9-A6D7FDA4B9BBQ48040604-E6EAF594-FF82-4A60-87EA-6EA2C327C484Q50227781-C2F5D7B7-99E3-411B-9F57-1286134FFC97Q51767077-D069CAA1-06AD-41B0-953E-EE52F6255E7B
P2860
Evaluation of Parkinson disease risk variants as expression-QTLs.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Evaluation of Parkinson disease risk variants as expression-QTLs.
@ast
Evaluation of Parkinson disease risk variants as expression-QTLs.
@en
Evaluation of Parkinson disease risk variants as expression-QTLs.
@nl
type
label
Evaluation of Parkinson disease risk variants as expression-QTLs.
@ast
Evaluation of Parkinson disease risk variants as expression-QTLs.
@en
Evaluation of Parkinson disease risk variants as expression-QTLs.
@nl
prefLabel
Evaluation of Parkinson disease risk variants as expression-QTLs.
@ast
Evaluation of Parkinson disease risk variants as expression-QTLs.
@en
Evaluation of Parkinson disease risk variants as expression-QTLs.
@nl
P2860
P50
P1433
P1476
Evaluation of Parkinson disease risk variants as expression-QTLs.
@en
P2093
Tiffany C Hadzi
P2860
P304
P356
10.1371/JOURNAL.PONE.0046199
P407
P577
2012-10-05T00:00:00Z